Tags: clinical trial

Cognixion, a California‑based startup, announced a clinical trial that pairs its noninvasive brain‑computer interface (BCI) with Apple’s Vision Pro headset. The trial aims to enable people with paralysis‑related speech disorders to communicate using brain signals captured by a custom headband equipped with six EEG sensors. Up to ten U.S. participants with conditions such as spinal‑cord injury, stroke, traumatic brain injury, or ALS will test the system, which combines AI‑driven language models with visual fixation detection. Cognixion’s goal is to democratize BCI technology by offering a low‑risk, widely accessible solution. Weiterlesen

Neuralink plans to start a new U.S. clinical trial in October that will test an implant designed to convert users' thoughts into written text. Conducted under an FDA investigational device exemption, the study aims to help individuals with speech impairments communicate directly via brain activity. The company already runs five other trials worldwide and envisions broader applications, including real‑time interaction with AI models and potential use by healthy users within a few years. Weiterlesen